Edition:
United Kingdom

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.51USD
8:59pm GMT
Change (% chg)

$0.53 (+5.31%)
Prev Close
$9.98
Open
$10.04
Day's High
$10.82
Day's Low
$10.04
Volume
10,942
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.66

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

Earnings vs. Estimates